Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Agenda - Information session on the pilot for expert panels' advice for orphan medical devices
Scientific advice under Article 115(5) of Regulation (EU) 2019/6 on veterinary medicinal products, regarding the list of substances essential for the treatment of equine species and for which the withdrawal period for equine species shall be six months
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) - 22 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 22 October 2024, 10:00 (CEST) to 22 October 2024, 10:30 (CEST)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - 29 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 10:30 (CET)
Q&A clinic on Product Management Service (PMS) Product User Interface (PUI) - 29 October 2024, Online, European Medicines Agency, Amsterdam, the Netherlands, from 29 October 2024, 10:00 (CET) to 29 October 2024, 10:30 (CET)
QRD statements for metered dose inhalers containing fluorinated greenhouse gases
Management Board meeting: 12 - 13 June 2024, European Medicines Agency, Amsterdam, the Netherlands, from 12 June 2024 to 13 June 2024
Minutes of the 124th meeting of the Management Board: 12-13 June 2024
Clinical Trials Regulation (CTR) Collaborate Stakeholder meeting, supported by ACT EU, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 11 September 2024, 13:00 (CEST) to 11 September 2024, 17:30 (CEST)
Herbal medicinal product: Rosmarini aetheroleumArray, F: Assessment finalised